Jury Begins Deliberations in Elizabeth Holmes Fraud Trial
Closing arguments conclude in the Theranos criminal fraud trial, leaving twelve jurors to decide if Elizabeth Holmes intentionally deceived investors and patients. The fallen startup founder faces up to 20 years in prison if convicted.
Closing arguments conclude in the criminal fraud trial of Elizabeth Holmes, leaving a twelve-person jury to decide the fate of the former Theranos CEO. After three months of testimony and dozens of witnesses, the jury receives instructions from the judge and begins deliberations. Holmes faces a maximum sentence of 20 years in prison if the jury finds her guilty of the fraud and conspiracy charges filed in 2018.
Prosecutors argue that Holmes intentionally exaggerates the capabilities of Theranos blood-testing machines to secure investments and mislead patients. They claim she chooses fraud over business failure when the startup runs out of money, falsely touting endorsements from pharmaceutical companies and the military. Meanwhile, Holmes's defense attorney tells the jury there is a fundamental disconnect in the government's case, insisting she shares her honest aspirations for the technology with long-term investors rather than intentionally deceiving them.
Holmes spends seven days on the witness stand, alternating between deflecting blame, claiming a lack of memory, and accepting responsibility for mistakes while denying any intent to deceive. The jury weighs her testimony against accounts from former employees who describe dangerous lab shortcuts and patients who receive inaccurate test results. Now, the jurors hold the power to determine whether the 37-year-old entrepreneur is a visionary who failed or a fraudster who deliberately lied.